<img alt="" src="https://secure.hear8crew.com/200126.png" style="display:none;">

Argentum Medical Announces Acquisition of Anacapa Technologies

June 22, 2022

Argentum Medical Announces Acquisition of Anacapa Technologies
Argentum Medical, pioneer of Silverlon® antimicrobial silver-plated dressings, expands its wound-care portfolio through acquisition of Anacapa Technologies’ antimicrobial wound cleansers, gels and irrigation product lines Acquisition Brings Together Two Leading Innovators in Antimicrobial Wound-Care Products

Geneva, Ill. (January 18, 2022) — Argentum Medical, a Shore Capital-backed medical device leader and pioneer of silver-plated nylon technology, today announced the acquisition of Anacapa Technologies’ antimicrobial wound cleansers, gels and irrigation product lines. Anacapa Technologies is a market leader and innovator in the formulation of antimicrobial wound care products. Argentum Medical acquired Anacapa Technologies to expand and enhance their wound-care portfolio with the addition of Anasept® and Silver-Sept® product lines. The transaction was completed on December 29, 2021.

Argentum Medical already provides a leading wound-care portfolio, consisting of Silverlon® antimicrobial silver-plated nylon dressings and TheraBond 3D® wound, surgical site and burn care dressings. To complement its current product portfolio, Argentum Medical will integrate Anacapa Technologies’ Anasept® and Silver-Sept® antimicrobial wound cleansers, gels and irrigation solutions with its current wound-care offering (all brand names will remain the same):

Argentum Medical Current Portfolio
• Silverlon wound care dressings are critical in helping to prevent infection in surgical, wound or burn victims. Silverlon antimicrobial silver-plated dressings have 50 to 100 times more metallic silver ions than other silver-impregnated dressings. Multiple, peer-reviewed, published clinical studies show the significant benefits of Silverlon in a wide variety of wound settings, including surgical, negative pressure, burn, skin graft, and IV and catheter-related wounds.

• TheraBond 3D wound care controls bioburden and minimizes maceration, TheraBond 3D surgical site care provides antimicrobial protection in a variety of post-op scenarios, and TheraBond 3D burn care utilizes unique capillary-like technology to transfer excess fluid away from burns to an outer absorbent dressing.

Argentum Medical Acquired Portfolio
• Anasept antimicrobial wound cleanser, gel and irrigation solution helps in the mechanical removal of debris, while delivering broad-spectrum antimicrobial to wound site to inhibit bacteria growth.

• Silver-Sept antimicrobial skin and wound gel that inhibits the growth of bacteria and helps maintain a moist wound environment conducive to healing.

With this portfolio, Argentum Medical provides clinicians with an extensive range of solutions for the
management of wounds, surgical sites and burns to improve patient outcomes.

“The acquisition of Anacapa Technologies’ wound care solutions continues our strategy to innovate patient care with the most sophisticated technologies and expand our growth in the wound-care space,” said Raul
Brizuela, president and CEO of Argentum Medical. “We are excited that Anacapa Technologies is now a part of the Argentum Medical/Cura Surgical family.”

Argentum Medical manufactures its products in the U.S. and will continue to market and distribute all its products domestically and internationally.

“I am proud that Argentum Medical will become the home for our innovations, and by joining forces, together we will help shape the future of wound-care,” said Wally Rogozinski, CEO and inventor of Anacapa
Technologies’ core products. “I look forward to seeing this innovative portfolio of products help patients and clinicians globally as part of Argentum Medical.”

Anacapa Technologies is headquartered in San Dimas, California. Upon completion of the transaction, Anacapa Technologies wound care solutions will become part of Argentum Medical.

SILVERLON® wound dressings have a permanently plated metallic surface, which provides the antimicrobial benefits of silver in the dressing without staining the skin and without increasing bioburden. SILVERLON® was originally developed for the U.S. military, where it is still extensively used for management of burn and blast injuries. SILVERLON® dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds. For more, visit Silverlon.com

Argentum Medical pioneered the use of silver-plated nylon. Specializing in the development of innovative products made from silver-plated nylon, the companies continue to explore new applications and markets for
SILVERLON® technology in keeping with their corporate mission to improve clinical outcomes.

Shore Capital, a Chicago-based private equity firm, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with
capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with
superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $2.4 billion of equity capital under
management through various investment vehicles. For more information, please visit: www.shorecp.com

Subscribe by Email